Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2022 / Cilt: 75 - Sayı: 1

Evaluation of the Effects of Different Antibiotic Combinations on Multi-Drug Resistant Gram-Negative Bacteria

Farklı Antibiyotik Kombinasyonlarının Çoklu İlaca Dirençli Gram-Negatif Bakteriler Üzerindeki Etkilerinin Değerlendirilmesi

Pages
28–35
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although further studies with more strains and different antibiotic combinations are needed for the appropriate treatment of infections due to multi-drug-resistant gram-negative bacteria, we found that colistin-tigecycline, colistin-sulbactam, colistin-rifampicin combinations are so effective for these strains in vitro and these results can help clinicians in treatment process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Increasing resistance to antibacterial drugs in gram-negative bacteria isolated from the community and especially from the hospital has become one of the most important health problems both in the world and in our country.
📊
Key Findings & Data:Acinetobacter genus and Enterobacteriacea family have an important place among gram-negative bacteria with increased antibacterial drug resistance.
💡
Conclusion & Impact:Conclusion: Although further studies with more strains and different antibiotic combinations are needed for the appropriate treatment of infections due to multi-drug-resistant gram-negative bacteria, we found that colistin-tigecycline, colistin-sulbactam, colistin-rifampicin combinations are so effective for these strains in vitro and these results can help clinicians in treatment process.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Increasing resistance to antibacterial drugs in gram-negative bacteria isolated from the community and especially from the hospital has become one of the most important health problems both in the world and in our country. Acinetobacter genus and Enterobacteriacea family have an important place among gram-negative bacteria with increased antibacterial drug resistance. In this study, we aimed to evaluate the in vitro effects of various antibiotic combinations with E-test method and determine synergistic effective combinations that could be used in multidrug resistant Acinetobacter baumannii infections and ESBL and carbapenemase secreting gram-negative enteric bacterial infections. Materials and Methods: It was evaluated whether the combinations of colistin with trimethoprim-sulfamethoxazole, rifampicin, doxycycline, sulbactam, imipenem, tigecycline and chloramphenicol were synergistic effective in vitro in 20 colistin-susceptible but multidrug-resistant, 20 colistin- and multi-drug-resistant Acinetobacter baumannii strains and 20 both extended-spectrum beta-lactamase and carbapenemase-producing Klebsiella pneumoniae strains isolated from various and different clinical samples (sputum, urine, tracheal aspirate, blood, etc.), sent from patients hospitalized in various clinics. Results: The synergistic effect was most common in the colistin-tigecycline combination in all multi-drug resistant bacterial groups, 80% in the colistin-sensitive Acinetobacter baumannii group, 45% in the colistin-resistant Acinetobacter baumannii group, and 80% in the Klebsiella pneumoniae group. Conclusion: Although further studies with more strains and different antibiotic combinations are needed for the appropriate treatment of infections due to multi-drug-resistant gram-negative bacteria, we found that colistin-tigecycline, colistin-sulbactam, colistin-rifampicin combinations are so effective for these strains in vitro and these results can help clinicians in treatment process.

Özet

Amaç: Toplumdan ve özellikle hastaneden izole edilen gram-negatif bakterilerde antibakteriyel ilaçlara direncin artması hem dünyada hem de ülkemizde en önemli sağlık sorunlarından biri haline gelmiştir. Artan antibakteriyel ilaç direnci açısından Acinetobacter cinsi ve Enterobacteriacea ailesi gram-negatif bakteriler arasında önemli bir yere sahiptir. Bu çalışmada, çeşitli antibiyotik kombinasyonlarının in vitro etkilerini E-test yöntemi ile değerlendirmeyi ve çoklu ilaca dirençli Acinetobacter baumannii enfeksiyonlarında ve GSBL ve karbapenemaz salgılayan gram negatif enterik bakteri enfeksiyonlarında kullanılabilecek sinerjik etkili kombinasyonları belirlemeyi amaçladık. Gereç ve Yöntem: Kolistinin trimetoprim-sülfametoksazol, rifampisin, doksisiklin, sulbaktam, imipenem, tigesiklin ve kloramfenikol ile kombinasyonlarının in vitro olarak sinerjistik etkili olup olmadığı, kolistine duyarlı ancak çoklu ilaca dirençli, kolistine ve çoklu ilaca dirençli 20’şer Acinetobacter baumannii ve genişlemiş spektrumlu beta-laktamaz ve karbapenemaz üreten 20 Klebsiella pneumoniae suşunda değerlendirildi. Bulgular: Sinerjistik etki, kolistin-tigesiklin kombinasyonunda tüm çoklu ilaca dirençli bakteri gruplarında en yaygın etki olarak bulundu. Kolistine duyarlı A. baumannii grubunda %80, kolistine dirençli Acinetobacter baumannii grubunda %45 ve Klebsiella pneumoniae grubunda %80 oranında görüldü. Sonuç: Çoklu ilaca dirençli gram-negatif bakterilere bağlı enfeksiyonların uygun tedavisi için daha fazla suş ve farklı antibiyotik kombinasyonları ile daha ileri çalışmalara ihtiyaç duyulsa da, kolistin-tigesiklin, kolistin-sulbaktam, kolistin-rifampisin kombinasyonlarının bu suşlar için in vitro olarak için çok etkili olduğu görüldü ve klinik uygulamalarda yol gösterici olabileceğini düşündük.

🔖

Cite This Article

ÇINAR, G., KALKAN, İ. A., BALIK, İ., BAYINDIR, Z., YALÇI, A., KUTLU, H., GERÇEKER, D., GÜRİZ, H. (2022). Evaluation of the Effects of Different Antibiotic Combinations on Multi-Drug Resistant Gram-Negative Bacteria. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 75 - Sayı: 1, 28–35. https://ajindex.com/articles/443399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34:1-14. de Kraker ME, Jarlier V, Monen JC, et al. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect. 2013;19:860-868.
  2. Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49:526-535.
  3. Srinivas P, Rivard K. Polymyxin Resistance in Gram-negative Pathogens. Curr Infect Dis Rep. 2017;19:38. Kumar A, Zarychanski R, Light B, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38:1773-1785.
  4. Morris S, Cerceo E. Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting. Antibiotics (Basel). 2020;9:196. Howard A, O’Donoghue M, Feeney A, et al. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3:243-250.
  5. Dandachi I, Azar E, Hamouch R, et al. Acinetobacter spp in a Third World Country with Socio-economic and Immigrants Challenges. J Infect Dev Ctries. 2019;13:948-955.
  6. Xie R, Zhang XD, Zhao Q, et al. Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. Emerg Microbes Infect. 2018;7:31. Şafak B, Kılınç O, Tunç N. Klinik örneklerden izole edilen Acinetobacter baumannii suşlarının antibiyotik duyarlılık oranlarının incelenmesi (2010- 2016). FLORA. 2016;21:77-81.
  7. Eroğlu C, Ünal N, Karadağ A, et al. Çeşitli klinik örneklerden 2006-2011 yılları arasında izole edilen Acinetobacter türleri ve antibiyotik duyarlılıkları. Turk Hij Den Biyol Derg. 2016;73:25-32.
  8. Haddad FA, Van Horn K, Carbonaro C, et al. Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test. Eur J Clin Microbiol Infect Dis. 2005;24:577-579.
  9. Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2003;22:28-34.
  10. Bonapace CR, White RL, Friedrich LV, et al.